pharmaceut firm bank reput isi founder troubl lure backer unexplor frontier biotechnolog isi pharmaceut presid stanley crook walk compani newli leas carlsbad facil took pain point despit mostli vacant offic laboratori space new biotechnolog firm hard work develop product temporari lab sorrento valley nearli empti build carlsbad research center symbol crook formid task build compani scratch pioneer unexplor frontier biotechnolog translat yet undevelop technolog market product crook 44 form isi two month ago illustri career head product research oper two major pharmaceut firm smithklin beckman bristol myer crook hold medic degre well doctor pharmacolog oversaw introduct 17 new drug 14 year two firm cheaper boston select san diego counti isi headquart could near grow biotechnolog commun cluster around uc san diego scripp clinic research foundat although hous expens san diego crook said cheaper boston san francisco bay area two headquart site consid carlsbad chosen counti locat favor leas rate said crook one three four best drug develop world base success smithklin bristol myer said christoph gabri gener partner bessem ventur partner menlo park base ventur capit firm invest eight biotechnolog compani includ isi describ drug develop enorm complex drawn expens process resign last summer crook vice presid charg smithklin research develop oper 300 million budget bristol myer left 1980 join smithklin crook help develop array chemotherapi drug cancer patient put bristol forefront cancer treatment trade visibl pharmaceut industri crook move fast sinc start isi march rais 5 2 million ventur capit hire 20 employe mani research star strong track record pharmaceut academia crook abl rais money five ventur capit firm includ bessem plu obtain commit 10 million next year even though isi may year away success technolog much less u food drug administr approv product compani payrol grow 20 30 employe year end mani 90 1990 said long long time sinc seen initi ventur fund 5 2 million said ray dittamor manag partner arthur young amp co firm whose client includ quarter san diego 70 biotechnolog compani includ isi tell lot investor biotech commun think crook team put togeth apart crook ventur capitalist interest revolv around technolog isi tri develop call anti sens oligonucleotid oligo bit dna bind messeng molecul sent dna caus product diseas bear protein bind diseas messeng call messeng rna oligo theoret prevent diseas messag pass thu ever produc crook said anti sens oligonucleotid method lot drug compani think go work isi one compani said ignacio tinoco professor chemistri univers california berkeley isi scientif advisori board idea instead attack diseas protein target rna caus synthes crook said potenti anti sens drug enorm could manufactur therapeut agent virtual diseas sinc virtual diseas start aberr protein set motion messeng rna molecul isi plan develop anti sens drug use call ration drug design comput aid process design drug forc thought crook said 2 billion market cite competit concern crook refus disclos diseas isi target first set product say howev compani pursu four market aggreg sale potenti 2 billion declin say whether aid one diseas target isi competit far includ san diego base genta compani spun recent gen probe publicli held manufactur dna probe diagnost product genta presid thoma adam unavail comment friday crook said expect major pharmaceut firm join field come year well although crook studi anti sens oligonucleotid better part two decad said becam convinc could use therapeut drug three year ago convict sprang advanc molecular biolog research enabl scientist clone synthes dna molecul crook also encourag scientist increas abil modifi manipul molecul process call hybrid bind one molecul anoth bind process isi anti sens nucleotid someday kill diseas caus rna molecul said crook said unabl gener much enthusiasm among smithklin colleagu pursu technolog perhap approach revolutionari combin smithklin financi problem last year result impact 3 000 scientist research program upper merion pa direct prompt crook resign return academia first crook plan leav drug compani return academia specif baylor colleg medicin houston faculti member past 15 year crook soon realiz enamor high stake game produc new drug social benefit success drug repres turn point medic career came young doctor houston watch 24 year old man die testicular cancer diseas larg curabl drug develop bristol myer crook tenur march isi sign agreement appli biosystem publicli held biotech compani foster citi lead manufactur instrument produc dna deal call two compani share right product develop isi expect appli biosystem help surmount formid problem produc anti sens drug adequ quantiti produc dna deriv exceedingli difficult anyth trace amount said almost like go moon consid make clinic kilogram dna said timothi geiser senior scientist appli biosystem difficulti product develop isi appli biosystem instead deriv substitut call dna analog geiser said compani expect sign similar agreement anti sens manufactur anti sens drug brand new field clear leader yet geiser said impress isi crook sever peopl experi drug develop say technolog give exclus edg term smart way ahead pack